The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

The data used to train the AI – including vaccination records, GP visits, hospital admissions, and A&E attendances – is being ...

AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...

Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...

A filing by the Department of Justice has asked Judge Matthew Kacsmaryk, a Trump appointee who opposes abortion, to block the ...

Financial terms of the new agreement include an upfront payment to secure rights to Alchemab's lead ALS candidate, ATLX-1282, ...

The NEJM has fired back a response to the Department of Justice (DoJ) asserting its "commitment to evidence-based ...

The phase 2 PIVOT-HD trial of Novartis-partnered PTC518 (votoplam) showed that the oral mRNA splicing modifier was able to ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

That is according to the chief executive of the American Association for the Advancement of Science (AAAS), Sudip Parikh, who ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the ...